Shareholder Alert: Robbins LLP Reminds Investors That Fennec Pharmaceuticals Inc. (FENC) is Being Sued for Misleading ShareholdersBusiness Wire • 02/14/22
FENNEC ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals Inc. and Encourages Investors to Contact the FirmBusiness Wire • 02/12/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of InvestorsBusiness Wire • 02/11/22
FENNEC PHARMACEUTICALS INC. (NASDAQ: FENC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals Inc. (NASDAQ: FENC)PRNewsWire • 02/11/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of InvestorsBusiness Wire • 02/11/22
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) InvestorsBusiness Wire • 02/11/22
Shareholder Alert: Robbins LLP Informs Investors that Fennec Pharmaceuticals Inc. (FENC) is Being Sued for Misleading ShareholdersBusiness Wire • 02/11/22
The Law Offices of Frank R. Cruz Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of InvestorsBusiness Wire • 02/11/22
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FENCBusiness Wire • 02/10/22
Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. (FENC) Investors of InvestigationBusiness Wire • 02/10/22
(FENC) NEWS: Did you Suffer a Substantial Loss? Contact Johnson Fistel About Leading Fennec Pharmaceuticals Class Action LawsuitNewsfile Corp • 02/10/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENCPRNewsWire • 12/13/21
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid TumorsGlobeNewsWire • 11/30/21
Fennec Pharma Stock Plunges On Expected FDA CRL For Pedmark For Chemo-Induced Hearing IssuesBenzinga • 11/29/21
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid TumorsGlobeNewsWire • 11/29/21
Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 11/10/21
Fennec Pharmaceuticals: Will Pedmark Make It To Market At Second Time Of Asking?Seeking Alpha • 10/29/21
Here's Why "Trend" Investors Would Love Betting on Adherex Technologies Inc. (FENC)Zacks Investment Research • 10/01/21
Here's Why Momentum in Adherex Technologies Inc. (FENC) Should Keep goingZacks Investment Research • 09/15/21
Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 08/10/21
Fennec Pharmaceuticals: The PEDMARK NDA Has Been Accepted, We Remain Bullish On The November PDUFA CatalystSeeking Alpha • 06/24/21